tiprankstipranks
Advertisement
Advertisement

HK:2617 Stock Latest News

TransThera Sciences Narrows Interim Loss as Revenue Emerges Amid Rising R&D Spend
Company AnnouncementsTransThera Sciences Narrows Interim Loss as Revenue Emerges Amid Rising R&D Spend
2d ago
2617
TransThera Sciences Sets Board Meeting to Review Interim Results and Potential Dividend
PremiumCompany Announcements
TransThera Sciences Sets Board Meeting to Review Interim Results and Potential Dividend
14d ago
2617
TransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma
PremiumCompany Announcements
TransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma
22d ago
2617
TransThera Grants Over 5.2 Million H-Share Awards and Options to Staff
PremiumCompany Announcements
TransThera Grants Over 5.2 Million H-Share Awards and Options to Staff
1M ago
2617
TransThera Wins NMPA Nod for Phase II Lung Cancer Trial of TT-00973 Combo
PremiumCompany Announcements
TransThera Wins NMPA Nod for Phase II Lung Cancer Trial of TT-00973 Combo
2M ago
2617
TransThera Completes Global Phase III Enrollment for Tinengotinib in Advanced Cholangiocarcinoma
PremiumCompany AnnouncementsTransThera Completes Global Phase III Enrollment for Tinengotinib in Advanced Cholangiocarcinoma
2M ago
2617
TransThera Wins China Nod for Phase II Trial of Novel BTK Inhibitor in Mantle Cell Lymphoma
Premium
Company Announcements
TransThera Wins China Nod for Phase II Trial of Novel BTK Inhibitor in Mantle Cell Lymphoma
2M ago
2617
TransThera Sciences to Launch Up to RMB100 Million H-Share Buyback
Premium
Company Announcements
TransThera Sciences to Launch Up to RMB100 Million H-Share Buyback
2M ago
2617
TransThera Sciences Sets Formal Terms for Audit Committee to Strengthen Governance
PremiumCompany Announcements
TransThera Sciences Sets Formal Terms for Audit Committee to Strengthen Governance
2M ago
2617
TransThera Sets Formal Nomination Committee Rules to Strengthen Board Governance
PremiumCompany Announcements
TransThera Sets Formal Nomination Committee Rules to Strengthen Board Governance
2M ago
2617
TransThera Sets Board Committee Rules to Tighten Pay and Performance Oversight
PremiumCompany Announcements
TransThera Sets Board Committee Rules to Tighten Pay and Performance Oversight
2M ago
2617
TransThera Sets Up Strategy Committee to Tighten Governance and Guide Long-Term Investments
PremiumCompany Announcements
TransThera Sets Up Strategy Committee to Tighten Governance and Guide Long-Term Investments
2M ago
2617
TransThera Wins Shareholder Approval for New H Share Award Scheme
PremiumCompany AnnouncementsTransThera Wins Shareholder Approval for New H Share Award Scheme
2M ago
2617
TransThera Shareholders Back Governance Revamp and Board Changes at 2026 AGM
Premium
Company Announcements
TransThera Shareholders Back Governance Revamp and Board Changes at 2026 AGM
2M ago
2617
TransThera Sciences Outlines Board and Committee Structure in Governance Update
Premium
Company Announcements
TransThera Sciences Outlines Board and Committee Structure in Governance Update
2M ago
2617
TransThera Sciences names industry veteran Sun Delong as chief operating officer
PremiumCompany Announcements
TransThera Sciences names industry veteran Sun Delong as chief operating officer
3M ago
2617
TransThera to Showcase Tinengotinib Phase II Data in FGFR2-Altered Cholangiocarcinoma at 2026 ASCO
PremiumCompany Announcements
TransThera to Showcase Tinengotinib Phase II Data in FGFR2-Altered Cholangiocarcinoma at 2026 ASCO
3M ago
2617
TransThera raises HK$152 million via H-share placing to fund Tinengotinib development
PremiumCompany Announcements
TransThera raises HK$152 million via H-share placing to fund Tinengotinib development
3M ago
2617
TransThera Sets 2026 AGM to Tackle Losses, Governance and New Share Mandate
PremiumCompany Announcements
TransThera Sets 2026 AGM to Tackle Losses, Governance and New Share Mandate
3M ago
2617
TransThera Wins China Phase II Trial Nod for Tinengotinib Combo in Resistant Prostate Cancer
PremiumCompany AnnouncementsTransThera Wins China Phase II Trial Nod for Tinengotinib Combo in Resistant Prostate Cancer
3M ago
2617
TransThera and Allist Launch Phase II Trial of TT-00973 and Firmonertinib Combo in EGFR-Mutant Lung Cancer
Premium
Company Announcements
TransThera and Allist Launch Phase II Trial of TT-00973 and Firmonertinib Combo in EGFR-Mutant Lung Cancer
3M ago
2617
TransThera Calls June 2026 EGM to Approve New H Share Award Scheme
Premium
Company Announcements
TransThera Calls June 2026 EGM to Approve New H Share Award Scheme
3M ago
2617

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >